BB Biotech AG 13D and 13G filings for Halozyme Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 5:01 pm Sale |
2020-12-31 | 13G | Halozyme Therapeutics, Inc. HALO |
BB Biotech AG | 3,970,000 2.900% |
-3,993,056 (-50.14%) |
Filing |